Cargando…

NALCN is a potential biomarker and therapeutic target in human cancers

Background: Sodium leak channel non-selective (NALCN), known as a voltage-independent Na(+) channel, is increasingly considered to play vital roles in tumorigenesis and metastasis of human cancers. However, no comprehensive pan-cancer analysis of NALCN has been conducted. Our study aims to explore t...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Jian, Xu, Jie, Chang, Zhiwei, Yan, Jiaqin, Zhang, Limin, Qin, Yanru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154523/ https://www.ncbi.nlm.nih.gov/pubmed/37152978 http://dx.doi.org/10.3389/fgene.2023.1164707

Ejemplares similares

Architecture of the human NALCN channelosome
por: Zhou, Lunni, et al.
Publicado: (2022)

Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer
por: Fang, Xuefen, et al.
Publicado: (2022)

Bioinformatics gene analysis of potential biomarkers and therapeutic targets of osteoarthritis associated myelodysplastic syndrome
por: Xin, Peicheng, et al.
Publicado: (2023)

Structure of the human sodium leak channel NALCN in complex with FAM155A
por: Xie, Jiongfang, et al.
Publicado: (2020)

REV1: A novel biomarker and potential therapeutic target for various cancers
por: Zhu, Ning, et al.
Publicado: (2022)

The sodium leak channel, NALCN, in health and disease
por: Cochet-Bissuel, Maud, et al.
Publicado: (2014)

Potential long non-coding RNAs to be considered as biomarkers or therapeutic targets in gastric cancer
por: Hajjari, Mohammadreza, et al.
Publicado: (2013)

DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer
por: Zeng, Yunqing, et al.
Publicado: (2022)

Lysine Acetylome Study of Human Hepatocellular Carcinoma Tissues for Biomarkers and Therapeutic Targets Discovery
por: Zhao, Qianwei, et al.
Publicado: (2020)

Aberrantly hypermethylated ARID1B is a novel biomarker and potential therapeutic target of colon adenocarcinoma
por: Baldi, Salem, et al.
Publicado: (2022)

The NALCN channel regulates metastasis and nonmalignant cell dissemination
por: Rahrmann, Eric P., et al.
Publicado: (2022)

Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease
por: Watson, Callum N., et al.
Publicado: (2019)

Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
por: Martinez, Victor G., et al.
Publicado: (2019)

NALCN channelopathies: Distinguishing gain-of-function and loss-of-function mutations
por: Bend, Eric G., et al.
Publicado: (2016)

LYPD3, a New Biomarker and Therapeutic Target for Acute Myelogenous Leukemia
por: Hu, Tingting, et al.
Publicado: (2022)

NPM1 is a Novel Therapeutic Target and Prognostic Biomarker for Ewing Sarcoma
por: Zhou, Yangfan, et al.
Publicado: (2021)

NALCN‐mediated sodium influx confers metastatic prostate cancer cell invasiveness
por: Folcher, Antoine, et al.
Publicado: (2023)

Malignant currents: sodium leak channel NALCN propels prostate cancer aggressiveness
por: Stejerean‐Todoran, Ioana, et al.
Publicado: (2023)

Novel NALCN variant: altered respiratory and circadian rhythm, anesthetic sensitivity
por: Lozic, Bernarda, et al.
Publicado: (2016)

Lack of current observed in HEK293 cells expressing NALCN channels
por: Egan, Jennifer M., et al.
Publicado: (2018)

The NALCN channel complex is voltage sensitive and directly modulated by extracellular calcium
por: Chua, H. C., et al.
Publicado: (2020)

MON-011 NALCN Expression Is Regulated by Progesterone and Estrogen in Human Myometrial Smooth Muscle Cells
por: Amazu, Chinwendu, et al.
Publicado: (2020)

Detecting Prognosis Risk Biomarkers for Colon Cancer Through Multi-Omics-Based Prognostic Analysis and Target Regulation Simulation Modeling
por: Yin, Zuojing, et al.
Publicado: (2020)

Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance
por: Kashyap, Dharambir, et al.
Publicado: (2023)

Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer
por: Lai, Li-Ting, et al.
Publicado: (2023)

Significant Gene Biomarker Tyrosine Kinase Non-receptor 2 Mediated Cell Proliferation and Invasion in Colon Cancer
por: Ling, Sunkai, et al.
Publicado: (2021)

Differential modulation of C. elegans motor behavior by NALCN and two-pore domain potassium channels
por: Zhou, Chuanman, et al.
Publicado: (2022)

TRPC3 and NALCN channels drive pacemaking in substantia nigra dopaminergic neurons
por: Um, Ki Bum, et al.
Publicado: (2021)

A Computational Framework to Identify Biomarkers for Glioma Recurrence and Potential Drugs Targeting Them
por: Ma, Shuzhi, et al.
Publicado: (2022)

Long Non-coding RNA: An Emerging Contributor and Potential Therapeutic Target in Renal Fibrosis
por: Xia, Weiping, et al.
Publicado: (2021)

Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules
por: Alotaibi, Faizah
Publicado: (2023)

Noncoding RNAs in human saliva as potential disease biomarkers
por: Lin, Xianzhi, et al.
Publicado: (2015)

Case Report: A de novo Variant in NALCN Associated With CLIFAHDD Syndrome in a Chinese Infant
por: Liao, Zhenyu, et al.
Publicado: (2022)

Identification of New Therapeutic Targets for Gastric Cancer With Bioinformatics
por: Li, Yang, et al.
Publicado: (2020)

Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer
por: Chen, Jianlin, et al.
Publicado: (2022)

EZH2-mediated H3K27me3 is a predictive biomarker and therapeutic target in uveal melanoma
por: Hou, Chen, et al.
Publicado: (2022)

Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker
por: Dong, Qiguan, et al.
Publicado: (2022)

Single-cell transcriptome sequencing reveals potential novel combination of biomarkers for antibody-based cancer therapeutics in hepatocellular carcinoma
por: Tang, Hong, et al.
Publicado: (2022)

SLO2.1/NALCN a sodium signaling complex that regulates uterine activity
por: Ferreira, Juan J., et al.
Publicado: (2021)

Structure of voltage-modulated sodium-selective NALCN-FAM155A channel complex
por: Kang, Yunlu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bj7onl2nf723k6svm74g4b1ejq